AKT1 and esophageal squamous cell carcinoma: By comparing the p‐ERK level with p‐AKT, our results revealed that inhibition of the ERK pathway plays a more crucial role in cetuximab‐mediated radiosensitivity of ESCC than dose the AKT pathway.